Simplex Trading
IRD

Simplex Trading’s Opus Genetics IRD Stock Holding History

Simplex Trading’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.52K Sell
1,100
-22,200
-95% -$104K ﹤0.01% 8235
2026
Q1 		$106K Buy
23,300
+17,800
+324% +$61.6K ﹤0.01% 5014
2025
Q4 		$11.1K Buy
+5,500
New +$11.2K ﹤0.01% 6922
2024
Q2 		– Sell
-9,400
Closed -$18K – 10031
2024
Q1 		$18K Sell
9,400
-5,500
-37% -$13.9K ﹤0.01% 7192
2023
Q4 		$44K Sell
14,900
-10,100
-40% -$29.9K ﹤0.01% 6214
2023
Q3 		$83K Sell
25,000
-3,800
-13% -$15.3K ﹤0.01% 5285
2023
Q2 		$124K Buy
28,800
+22,800
+380% +$108K ﹤0.01% 4830
2023
Q1 		$22K Buy
6,000
+3,400
+131% +$12.2K ﹤0.01% 6839
2022
Q4 		$9K Sell
2,600
-47,600
-95% -$125K ﹤0.01% 7674
2022
Q3 		$100K Buy
50,200
+5,800
+13% +$12.5K ﹤0.01% 5540
2022
Q2 		$85K Buy
44,400
+43,000
+3,071% +$97.7K ﹤0.01% 5789
2022
Q1 		$4K Sell
1,400
-114,700
-99% -$393K ﹤0.01% 9610
2021
Q4 		$433K Buy
116,100
+105,300
+975% +$422K ﹤0.01% 4015
2021
Q3 		$57K Buy
+10,800
New +$49.8K ﹤0.01% 7370

Other funds holding IRD

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Simplex Trading's IRD Position: Q2 2026 in Review

Simplex Trading reduced its Opus Genetics (IRD) stake by 69% in Q2 2026, selling an estimated $266K and leaving 25,553 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #5483.

Simplex Trading first reported a position in IRD in Q1 2022 and has held it in 12 quarters since. The position peaked at $375K in Q1 2026. 103 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

  • Simplex Trading held 25,553 shares of Opus Genetics worth $105K as of Q2 2026.
  • Simplex Trading sold 56,927 Opus Genetics shares in Q2 2026, an estimated $266K.
  • Opus Genetics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #5483 holding.
  • Simplex Trading first reported a position in Opus Genetics in Q1 2022 and has held it in 12 quarters since.
  • Simplex Trading's Opus Genetics position peaked at $375K in Q1 2026.
  • 103 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.